DUBLIN, November 22, 2013 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/7kx2mv/cns_therapeutics) have announced the addition of the "CNS Therapeutics - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for CNS Therapeutics in US$ Million by the following Product Groups: Anti-Alzheimers, Anti-Parkinsons, Anti-Epilepsy, Pain Management (includes Migraine, Nociceptive and neuropathic pain), Anti-Psychotics, Anti-Depressants, and Others (includes Multiple Sclerosis, Insomnia and ADHD). The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018.
The report profiles 127 companies including many key and niche players such as AbbVie Inc., Alkermes Plc, Amneal Pharmaceuticals, LLC, Aspen Pharmacare Holdings Limited, AstraZeneca Plc, BEACON Pharmaceutical Limited, BIAL Group, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Dainippon Sumitomo Pharma Co., Ltd., Eisai Co., Ltd., Elan Corporation Plc, Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Fabre-Kramer Pharmaceuticals, Inc., Forest Laboratories, Inc., GlaxoSmithKline, H. Lundbeck A/S, Johnson & Johnson, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Neurocrine Biosciences, Inc., Novartis AG, Otsuka Pharmaceutical Co., Ltd., Pfizer, Inc., Sanofi S.A, Shire Plc, Sunovion Pharmaceuticals, Inc., Takeda Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Ltd., and UCB Group.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
II. Executive Summary
1. INDUSTRY OVERVIEW
2. MARKET OVERVIEW & TRENDS ACROSS CNS THERAPEUTIC AREAS
3. CHANGING HEALTHCARE INDUSTRY IN EUROPE & THE UNITED STATES
4. PRODUCT OVERVIEW
5. REVIEW OF SELECT CNS DRUGS
6. RESEARCH & DEVELOPMENT
7. PRODUCT INTRODUCTIONS/INNOVATIONS
8. RECENT INDUSTRY ACTIVITY
9. FOCUS ON SELECT GLOBAL PLAYERS
10. GLOBAL MARKET PERSPECTIVE
1. THE UNITED STATES
5. LATIN AMERICA
6. REST OF WORLD
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 127 (including Divisions/Subsidiaries - 157)
For more information visit http://www.researchandmarkets.com/research/7kx2mv/cns_therapeutics
|SOURCE Research and Markets|
Copyright©2012 PR Newswire.
All rights reserved